Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

2nd ADC Target Selection Summit

Evvnt Promotion / evvnt
-
06.12.2022 - 08.12.2022  Hilton Boston Logan Airport, One Hotel Drive, 02128 Boston, Massachusetts, USA
Time: 09:00 - 16:00
 
Temi della conferenza
With no room for error in the highly competitive ADC market and no going back after you have selected your target, it is vital that drug developers optimally triangulate the linker-payload, target and indication to develop an ADC that can have the biggest impact on patients.

Recent exciting developments in linker-payload technologies and clinical efficacy in low-expressed tumors have propelled this conversation to the forefront of mind.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/1261856-3?pid=4832

Speakers: Jagath Reddy Junutula, President, Chief Executive Officer and Co-Founder, Aarvik Therapeutics, Yu Shen, Director, Oncology Discovery, AbbVie, and more.
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/1261856-2?pid=4832
Ms. Aarti Diwan
 
Categorie
Oncologia
Lingua
Inglese
Quote del Congresso
USD 2499.00 - USD 4697.00
I partecipanti attesi
500 - 500
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Ärztekammer für WienEuropean Health Forum GasteinAMREF - African Medical and Research FoundationCharité International AcademyHelix - Forschung & Beratung WienHilfswerk AustriaEuropean Public Health Association (EUPHA)Centro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio Sanitario